Ingevity Corporation
Ingevity Corporation Fundamental Analysis
Ingevity Corporation (NGVT) shows weak financial fundamentals with a PE ratio of -13.80, profit margin of -13.51%, and ROE of -1.28%. The company generates $1.2B in annual revenue with weak year-over-year growth of -16.98%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -137.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze NGVT's fundamental strength across five key dimensions:
Efficiency Score
WeakNGVT struggles to generate sufficient returns from assets.
Valuation Score
ExcellentNGVT trades at attractive valuation levels.
Growth Score
ModerateNGVT shows steady but slowing expansion.
Financial Health Score
ModerateNGVT shows balanced financial health with some risks.
Profitability Score
WeakNGVT struggles to sustain strong margins.
Key Financial Metrics
Is NGVT Expensive or Cheap?
P/E Ratio
NGVT trades at -13.80 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, NGVT's PEG of 0.09 indicates potential undervaluation.
Price to Book
The market values Ingevity Corporation at 77.66 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 55.72 times EBITDA. This signals the market has high growth expectations.
How Well Does NGVT Make Money?
Net Profit Margin
For every $100 in sales, Ingevity Corporation keeps $-13.51 as profit after all expenses.
Operating Margin
Core operations generate 21.83 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.28 in profit for every $100 of shareholder equity.
ROA
Ingevity Corporation generates $-10.12 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ingevity Corporation generates strong operating cash flow of $333.65M, reflecting robust business health.
Free Cash Flow
Ingevity Corporation generates strong free cash flow of $275.52M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $7.66 in free cash annually.
FCF Yield
NGVT converts 11.85% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-13.80
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
77.66
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.88
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
41.84
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.15
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.28
vs 25 benchmark
ROA
Return on assets percentage
-0.10
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How NGVT Stacks Against Its Sector Peers
| Metric | NGVT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -13.80 | 24.91 | Better (Cheaper) |
| ROE | -127.78% | 840.00% | Weak |
| Net Margin | -13.51% | -105381.00% (disorted) | Weak |
| Debt/Equity | 41.84 | 0.55 | Weak (High Leverage) |
| Current Ratio | 1.15 | 4.94 | Neutral |
| ROA | -10.12% | -4176.00% (disorted) | Weak |
NGVT outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ingevity Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
9.54%
Industry Style: Cyclical, Commodity, Value
GrowingEPS CAGR
-205.09%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
7.22%
Industry Style: Cyclical, Commodity, Value
Growing